Physician profile
Daniel Ryan Baker
NPI 1295327393
$6,152.38
in general payments reported to CMS, 2019-2025
23 companies · $1,959 in 2025
The $1,959 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $271 · 2022: $571 · 2023: $459 · 2024: $2,892 · 2025: $1,959.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,071 · Travel and Lodging: $1,238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,071.44 |
| Travel and Lodging | $1,238.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,851.04 | 2022-2025 | Eterna, Proclaim |
| Medtronic, INC. | $1,178.78 | 2021-2025 | Synchromedii, Inceptiv, Kyphon Express II Kyphopak Tray |
| Curonix LLC | $1,008.60 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Foundation Fusion Solutions, LLC | $509.13 | 2024-2025 | |
| Abbvie INC. | $363.45 | 2022-2025 | |
| Spinal Simplicity, LLC | $232.54 | 2024-2025 | Ha Minuteman G3-R |
| Tersera Therapeutics LLC | $168.67 | 2024-2025 | Prialt |
| Amgen INC. | $151.43 | 2021-2022 | |
| Globus Medical, INC. | $147.10 | 2025 | Senza, Corridor |
| Boston Scientific Corporation | $76.69 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Ipsen Biopharmaceuticals, INC | $74.64 | 2025 | Dysport |
| Lilly USA, LLC | $64.80 | 2024 | Emgality |
| Si-Bone, INC. | $63.97 | 2023-2025 | |
| Nevro Corp. | $55.22 | 2022-2023 | Senza |
| Depuy Synthes Sales INC. | $40.89 | 2025 | Confidence Spinal Cement System |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $28.33 | 2024 | Generator |
| Merz Pharmaceuticals, LLC | $24.17 | 2024 | Xeomin |
| Nalu Medical, INC. | $23.62 | 2024 | Nalu Neurostimulation System |
| Pacira Pharmaceuticals Incorporated | $19.83 | 2022 | |
| Mml US, INC. | $19.12 | 2025 | Reactiv8 |
| Biotronik Nro, INC. | $18.63 | 2025 | Prospera |
| Averitas Pharma INC. | $17.69 | 2023 | Qutenza |
| Pfizer INC. | $14.04 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.